Search tool

Displaying 1 - 9 of 9

Video thumbnail: naloxone

Video: Take-home naloxone programmes in Europe — overdose prevention

Drug overdose continues to be the main cause of death among problem drug users and heroin or its metabolites are present in the majority of reported fatal overdoses. Naloxone is a lifesaving...

Document library

Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) – Preliminary summary and highlights of the meeting

Two EMCDDA expert meetings, dedicated to the agency’s drug-related deaths and mortality among drug users indicator (DRD) and the drug-related infectious diseases indicator (DRID), were held in Lisbon from 15–17 October. This...

document cover

Document library

Meeting minutes: Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe, October 2014

These are the minutes from a meeting organised by the EMCDDA on 14 October 2014 in Lisbon, entitled 'Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe'. The...

Document library

Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe (meeting report)

Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe

Drug overdose continues to be the main cause of death among problem drug users and heroin or its metabolites are present in the majority of reported fatal overdoses, often in combination with...

Lisbon, Portugal

EMCDDA expert meeting

Document library

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region

This systematic review indicates that hepatitis C treatment uptake is relatively low among drug users in several European countries, and also points to considerable knowledge gaps regarding treatment uptake levels in this...

Document library

Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis

Identifies key actions suggested by lessons learned from the three-plus decades of the HIV epidemic which can be applied to the prevention of hepatitis among drug users.

Document library

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Stronger efforts are needed to improve data availability to guide an increase in HCV treatment among PWID.

Document library

Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West

Despite the absolute differences in reported risk behaviours among PWID in western and eastern Europe, the associations of risk behaviours with HIV status were similar across the sites and regions. HIV prevention...